Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5351 - 5353 of 5353 in total
Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb, each of which contributes one heavy chain and one light chain to drug structure. The resulting 4-chain bispecific...
Approved
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G2 (224-ARGININE,265-ALANINE,330-SERINE,331-SERINE), ANTI-(HUMAN CD3 ANTIGEN .EPSILON. ... B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB …
Matched Description: … immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and ... an anti-CD3 mAb,[A261060] each of which contributes one heavy chain and one light chain to drug structure ... [L47815] On August 14, 2023, the FDA granted accelerated approval to elranatamab for the treatment of …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Investigational
Matched Synonyms: … 124I-p5+14 ... Evuzamitide Iodine I-124 ... IODINE I 124 EVUZAMITIDE …
Matched Name: … Iodine I-124 Evuzamitide …
Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Investigational
Matched Synonyms: … Na-1
Matched Description: … Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Displaying drugs 5351 - 5353 of 5353 in total